← back to database
Research Corporation Technologies invests in startup and early-stage companies developing patented biomedical products, particularly biotechnology therapeutics and tools and medical devices. Initial commitments range from several hundred thousand to several million dollars, with reserves for follow-ons.
Stage focus
Lead / follow
Check size
Specialization
Generalist / Specialist
Specialist
Latest fund size
More than $500 million in corporate assets available for technology investment
Investing team
- Brad MorieSenior Director, Biotechnologies
- Chad W. SouvignierVice President
- David A. WiersmaSenior Associate
- Paul HoerbeltDirector, Biotechnologies
- Shaun A. KirkpatrickPresident, Biotechnologies
- William KellyAssociate